Bank of England set to raise base rates to 4%

Central banks in UK, Europe and the US all set to raise rates

Silence Therapeutics plc (SLNCF)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

3.2500

0.0000

(0.00%)

As of 03:58PM EST. Market open.

Loading interactive chart…

Zacks
Zacks Industry Outlook Highlights Dyne Therapeutics, Silence Therapeutics, Alaunos Therapeutics, Assertio Holdings and Acer Therapeutics
Dyne Therapeutics, Silence Therapeutics, Alaunos Therapeutics, Assertio Holdings and Acer Therapeutics are part of the Zacks Industry Outlook article.
Zacks
5 Stocks to Buy as the Drug Industry Bets Big on Innovation
Innovation is expected to continue driving growth in the Medical-Drugs industry in 2023. DYN, SLN, TCRT, ASRT and ACER may prove to be good additions to one's portfolio.
Business Wire
Silence Therapeutics Provides SLN360 and SLN124 Clinical Program Updates
LONDON, January 12, 2023--Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines, today provided the following SLN360 and SLN124 program updates during a presentation at the 41st Annual J.P. Morgan Healthcare Conference: